Developer of biosimilar theraputics
S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

S.934 - FDA Reauthorization Act of 2017 - All issues related to the development and marketing of biosimilar medications. 

H.R. 2797 - FDA Reauthorization Act of 2017 - All issues related to the development and marketing of biosimilar medications. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. 

Issues related to the maintenance of current IPR laws. S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

S.934 - FDA Reauthorization Act of 2017 - All issues related to the development and marketing of biosimilar medications. 

H.R. 2797 - FDA Reauthorization Act of 2017 - All issues related to the development and marketing of biosimilar medications. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. 

Issues related to the maintenance of current IPR laws.
MMM - Medicare/Medicaid HCR - Health Issues PHA - Pharmacy
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON